Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126754753 | 12675475 | 3 | F | 20160824 | 20160823 | 20160906 | EXP | GB-MHRA-ADR 23597410 | GB-ACCORD-043228 | ACCORD | 0.00 | F | Y | 0.00000 | 20160906 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126754753 | 12675475 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | RESHAP CHEMOTHERAPY | U | 206774 | ||||||||||
| 126754753 | 12675475 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | RESHAP CHEMOTHERAPY | U | 74513 | ||||||||||
| 126754753 | 12675475 | 3 | SS | DOXORUBICIN/DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | RCHOP CHEMOTHERAPY, LIPOSOMAL INJECTION | U | 0 | INJECTION | ||||||||
| 126754753 | 12675475 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | RCHOP CHEMOTHERAPY, DOSAGE FORM: UNKNOWN | U | 0 | |||||||||
| 126754753 | 12675475 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | RCHOP CHEMOTHERAPY, FIRST DOSE, DOSAGE FORM: UNKNOWN | U | 0 | |||||||||
| 126754753 | 12675475 | 6 | SS | RITUXIMAB | RITUXIMAB | 1 | FIRST DOSE OF RCHOP CHEMOTHERAPY,?DOSAGE FORM: UNKNOWN | U | 0 | ||||||||||
| 126754753 | 12675475 | 7 | SS | CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE | CYCLOPHOSPHAMIDE | 1 | FIRST DOSE OF RCHOP CHEMOTHERAPY, DOSAGE FORM: UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126754753 | 12675475 | 1 | Neoplasm malignant |
| 126754753 | 12675475 | 2 | Neoplasm malignant |
| 126754753 | 12675475 | 3 | Diffuse large B-cell lymphoma |
| 126754753 | 12675475 | 4 | Diffuse large B-cell lymphoma |
| 126754753 | 12675475 | 5 | Diffuse large B-cell lymphoma |
| 126754753 | 12675475 | 6 | Lymphoma |
| 126754753 | 12675475 | 7 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126754753 | 12675475 | OT |
| 126754753 | 12675475 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126754753 | 12675475 | Alopecia | |
| 126754753 | 12675475 | Disease progression | |
| 126754753 | 12675475 | Hiccups | |
| 126754753 | 12675475 | Infection | |
| 126754753 | 12675475 | Neoplasm progression | |
| 126754753 | 12675475 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |